Cargando…

Efficacy of Anti-Sars-Cov-2 mRNA Vaccines in Adults with Severe Acquired Aplastic Anemia with or without Allograft

Detalles Bibliográficos
Autores principales: Garnier, Alice, Le Bourgeois, Amandine, Guillaume, Thierry, Peterlin, Pierre, Jullien, Maxime, Coste-Burel, Marianne, Bene, Marie C, Chevallier, Patrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology. Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665280/
http://dx.doi.org/10.1182/blood-2022-164807
_version_ 1784831257040912384
author Garnier, Alice
Le Bourgeois, Amandine
Guillaume, Thierry
Peterlin, Pierre
Jullien, Maxime
Coste-Burel, Marianne
Bene, Marie C
Chevallier, Patrice
author_facet Garnier, Alice
Le Bourgeois, Amandine
Guillaume, Thierry
Peterlin, Pierre
Jullien, Maxime
Coste-Burel, Marianne
Bene, Marie C
Chevallier, Patrice
author_sort Garnier, Alice
collection PubMed
description
format Online
Article
Text
id pubmed-9665280
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The American Society of Hematology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-96652802022-11-16 Efficacy of Anti-Sars-Cov-2 mRNA Vaccines in Adults with Severe Acquired Aplastic Anemia with or without Allograft Garnier, Alice Le Bourgeois, Amandine Guillaume, Thierry Peterlin, Pierre Jullien, Maxime Coste-Burel, Marianne Bene, Marie C Chevallier, Patrice Blood Poster Abstracts The American Society of Hematology. Published by Elsevier Inc. 2022-11-15 2022-11-15 /pmc/articles/PMC9665280/ http://dx.doi.org/10.1182/blood-2022-164807 Text en Copyright © 2022 The American Society of Hematology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Poster Abstracts
Garnier, Alice
Le Bourgeois, Amandine
Guillaume, Thierry
Peterlin, Pierre
Jullien, Maxime
Coste-Burel, Marianne
Bene, Marie C
Chevallier, Patrice
Efficacy of Anti-Sars-Cov-2 mRNA Vaccines in Adults with Severe Acquired Aplastic Anemia with or without Allograft
title Efficacy of Anti-Sars-Cov-2 mRNA Vaccines in Adults with Severe Acquired Aplastic Anemia with or without Allograft
title_full Efficacy of Anti-Sars-Cov-2 mRNA Vaccines in Adults with Severe Acquired Aplastic Anemia with or without Allograft
title_fullStr Efficacy of Anti-Sars-Cov-2 mRNA Vaccines in Adults with Severe Acquired Aplastic Anemia with or without Allograft
title_full_unstemmed Efficacy of Anti-Sars-Cov-2 mRNA Vaccines in Adults with Severe Acquired Aplastic Anemia with or without Allograft
title_short Efficacy of Anti-Sars-Cov-2 mRNA Vaccines in Adults with Severe Acquired Aplastic Anemia with or without Allograft
title_sort efficacy of anti-sars-cov-2 mrna vaccines in adults with severe acquired aplastic anemia with or without allograft
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665280/
http://dx.doi.org/10.1182/blood-2022-164807
work_keys_str_mv AT garnieralice efficacyofantisarscov2mrnavaccinesinadultswithsevereacquiredaplasticanemiawithorwithoutallograft
AT lebourgeoisamandine efficacyofantisarscov2mrnavaccinesinadultswithsevereacquiredaplasticanemiawithorwithoutallograft
AT guillaumethierry efficacyofantisarscov2mrnavaccinesinadultswithsevereacquiredaplasticanemiawithorwithoutallograft
AT peterlinpierre efficacyofantisarscov2mrnavaccinesinadultswithsevereacquiredaplasticanemiawithorwithoutallograft
AT jullienmaxime efficacyofantisarscov2mrnavaccinesinadultswithsevereacquiredaplasticanemiawithorwithoutallograft
AT costeburelmarianne efficacyofantisarscov2mrnavaccinesinadultswithsevereacquiredaplasticanemiawithorwithoutallograft
AT benemariec efficacyofantisarscov2mrnavaccinesinadultswithsevereacquiredaplasticanemiawithorwithoutallograft
AT chevallierpatrice efficacyofantisarscov2mrnavaccinesinadultswithsevereacquiredaplasticanemiawithorwithoutallograft